Condition
Complete DiGeorge Anomaly
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
75%
3 of 4 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (2)
P 2 (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05329935RecruitingPrimary
Congenital Athymia Patient Registry
NCT01220531Not ApplicableCompletedPrimary
Thymus Transplantation Safety-Efficacy
NCT00579709Phase 1Completed
Thymus Transplantation With Immunosuppression
NCT00576836Phase 2Completed
Thymus Transplantation Dose in DiGeorge #932
NCT00579527Phase 1Completed
Phase I/II Thymus Transplantation With Immunosuppression #950
Showing all 5 trials